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Abstract 
Adherence to treatment is a key element for global TB control. Public health laws can be used to enforce 
isolation, adherence, and completion of TB treatment. However, the practical application of public 
health laws can potentially range from voluntary measures to involuntary detention approaches. This 
paper explores the potential risks and impacts of using detention approaches to enforce TB treatment 
adherence. In August 2015, we conducted a literature search regarding the application of public health 
laws to enforce adherence to TB treatment globally, and specifically in Kenya. Texts were analyzed using 
narrative synthesis. Results indicated that in Kenya, people lost to follow-up on TB treatment were 
frequently detained in prisons. However, incarceration and detention approaches curtail the rights to 
health, informed consent, privacy, freedom from non-consensual treatment, freedom from inhumane and 
degrading treatment, and freedom of movement of people lost to follow-up. Detention could also worsen 
social inequalities and lead to a paradoxical increase in TB incidence. We suggest the incorporation of 
less intrusive solutions in legislation and policies. These include strengthening health systems to reduce 
dependency on prisons as isolation spaces, decentralizing TB treatment to communities, enhancing 
treatment education, revising the public health laws, and addressing socioeconomic and structural 
determinants associated with TB incidence and loss to follow-up.
Gitau Mburu, MD, DTM&H, MPH, is a Senior Advisor for HIV and Health Systems at the International HIV/AIDS Alliance, Brighton, 
United Kingdom.
Enrique Restoy, MA, PhD, is Senior Human Rights Advisor at the International HIV/AIDS Alliance, Brighton, United Kingdom.
Evaline Kibuchi, MA, PGD, is Chief National Coordinator of the Stop TB Partnership, Kenya.
Paula Holland, MA(Econ), PhD, is a Lecturer in Public Health in the Division of Health Research at Lancaster University, United 
Kingdom.
Anthony D. Harries, OBE, MA, MD, FRCP, DTM&H, is Senior Advisor and Director of the Department of Research at the 
International Union Against Tuberculosis and Lung Disease, Paris, France, and an honorary professor at the London School of Hygiene 
and Tropical Medicine, London, United Kingdom.
Please address correspondence to the authors c/o Gitau Mburu, International HIV/AIDS Alliance, Preece House, 91-101 Davigdor Road, 
Hove, East Sussex, BN3 1RE, UK. Email: gmburu@aidsalliance.org.
Competing interests: None declared.
Copyright © 2016 Mburu, Restoy, Kibuchi, Holland, and Harries. This is an open access article distributed under the terms of the 
Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted 
non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
Health and Human Rights Journal
HHr
HHR_final_logo_alone.indd   1 10/19/15   10:53 AM
G. Mburu, E. Restoy, E. Kibuchi, P. Holland, and A. D. Harries  / TB and the Right to Health, 43-54
44
J U N E  2 0 1 6    V O L U M E  1 8    N U M B E R  1   Health and Human Rights Journal
Introduction 
The World Health Organization (WHO) estimates 
that 9 million people develop tuberculosis (TB) 
annually, a sixth of whom die as a result.1 In 2014, 
this translated to 1.6 million deaths, of which more 
than 90% were in developing countries.2 The clus-
tering of TB in low- and middle-income countries 
is not surprising. An increasing amount of evi-
dence suggests that individual vulnerability to TB 
is determined by risk factors that are often related 
to a person’s social and economic position. This 
association has led some commentators to label 
TB as “traditionally a disease of the poor.”3 TB is 
associated with being malnourished, smoking, al-
cohol abuse, exposure to indoor air pollution, and 
living or working in crowded and poorly ventilat-
ed conditions.4 TB prevalence is also high among 
individuals confined in prisons.5 There is consider-
able evidence that people in lower socioeconomic 
groups are, on average, more likely to possess these 
risk factors or determinants, including those living 
in developed countries.6 Consequently, although 
context-specific differences may exist, overall, TB 
is more common in developing countries, where 
poverty, poor housing conditions, and indoor air 
pollution are more frequent, and expenditure on 
health is low.7 Over 80% of TB cases and deaths 
occur in low- and middle-income countries, and 
80% of the global burden of TB is concentrated in 
just 22 countries, of which 20 are Asian or African.8 
 Kenya is among the 22 countries with the 
highest burden of TB, and in 2014, there were an 
estimated 110,000 TB cases.9 The prevalence of mul-
tidrug-resistant TB (MDR-TB: TB that is resistant to 
the two main first-line anti-TB drugs isoniazid and 
rifampicin) has increased in Kenya over the last few 
years, from 0.04% in 2005 to 0.16% in 2011—a four-
fold increase in six years, partly because of poor 
adherence.10 Evidence suggests that MDR-TB is par-
ticularly common in deprived neighborhoods. Two 
studies conducted between 2011 and 2012 showed 
that the level of MDR-TB in Nairobi’s Kibera slums 
was typically between 0.5% and 1% among new TB 
cases and 8.5% among recurrent TB cases.11 Because 
MDR-TB is difficult and more expensive to treat, its 
case fatality rate is almost twice that of drug-suscep-
tible TB.12 Given the increased risk of transmission of 
pulmonary TB, treatment completion and infection 
control are emphasized.13 
Although of public health importance, ad-
herence to a full course of TB treatment is not 
always easy. A full course of treatment involves a 
combination of four drugs taken orally, daily, for 
two months, followed by two drugs taken orally 
for four months.14 A recent systematic review 
demonstrated a range of factors that contribute 
to poor adherence to TB drugs globally, includ-
ing poor availability and organization of health 
services, local interpretations of illness, financial 
burdens around accessing treatment, poor knowl-
edge or negative attitudes about TB, side effects 
of TB drugs, and lack of family support.15 This 
contextualization is central to our understanding 
of the impact of incarceration and compulsory 
detention approaches of enforcing adherence to 
TB treatment, which is the focus of this paper. 
 In general terms, combinations of down-
stream and upstream interventions are used to 
facilitate adherence. An example of a downstream 
strategy is the WHO DOTS strategy (Directly 
Observed Treatment, Short Course) which was 
conceived in 1994 specifically to support detection 
and successful treatment of TB.16 One component 
of the DOTS strategy is direct observation of treat-
ment, either by a health care provider or family 
member. One of the targets of the DOTS strategy is 
to achieve 85% treatment success, that is, 85% of TB 
patients complete their treatment and are declared 
no longer infectious.17 This target has been achieved 
in many countries. For example, in 2011, the treat-
ment success among 82,000 people on TB therapy 
in Kenya was 86%.18 However, as we argue in this 
paper, this target has partly been achieved through 
a process involving involuntary enforcement of 
adherence, specifically through incarceration, 
raising concerns regarding the appropriateness of 
these approaches to achieve treatment objectives. 
 Although an ongoing challenge is to ensure 
that all people with TB (estimated to be about 
110,000 cases per year in Kenya) are detected and 
started on treatment, mandatory isolation and its 
impact on individuals with TB, as well as overall 
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prevalence rates, need to be better understood.19 
Mandatory isolation is an example of an upstream 
intervention applied for the purposes of infectious 
disease containment, including TB. This “typically 
involves detection, notification, quarantine, and 
isolation of actual or suspected cases, the protec-
tion and monitoring of those not infected, and 
possibly even treatment” for those infected.20 In 
many countries, public health laws provide powers 
to enforce isolation and compulsory treatment 
of TB.21 However, the extent of the application of 
this strategy and its potential impact on individ-
ual rights is poorly documented. The aim of this 
paper is therefore to describe the potential risks 
of incarceration and compulsory detention as a 
means of enforcing adherence to TB treatment, and 
to suggest human rights-based alternatives to this 
approach, using Kenya as an example.
Methods
In August 2015, we conducted a literature search 
regarding the application of public health laws 
as an instrument for enforcing adherence to TB 
treatment globally, and specifically in Kenya. We 
searched Medline, PubMed, Social Policy and Prac-
tice, and Web of Science for peer-reviewed articles, 
and searched websites of global health governance 
institutions such as WHO, the Global Fund to Fight 
AIDS, Tuberculosis and Malaria, PEPFAR/USAID, 
as well as Google Scholar, for grey literature. The 
search was performed using a combination of 
terms relating to TB (‘TB’, ‘tuberculosis’), public 
health laws (‘law’, ‘public health act’, ‘control act’, 
‘disease act’ and ‘health law’), and adherence 
(‘compliance’, ‘default’, ‘loss to follow-up’, and 
‘treatment completion’). Truncation, Boolean, and 
proximity operators were used when appropriate to 
increase sensitivity of the search. Two authors (GM 
and ER) identified relevant articles, focusing on 
human rights aspects of public health responses to 
TB and other communicable diseases. Analysis of 
the results was conducted using narrative synthesis 
in which relevant information is collated to inform 
practice and policy.22 In our analysis, we aimed to 
compare the practice and application of the Public 
Health Act in Kenya with that described in other 
countries, using recent reports of how the Act has 
been used in Kenya as a starting point. We did not 
perform in-depth scrutiny of the Public Health Act 
itself, apart from its application. 
Results 
International human rights standards and 
public health laws 
We identified evidence of the existence of public 
health laws for the purpose of controlling infectious 
diseases in different contexts, including in Europe, 
Asia, Middle East, North America, and South Af-
rica, among others.23 Public health laws are widely 
applied to facilitate international containment of 
infectious diseases and achieve health protection, 
for instance, through TB screening at international 
border points.24 Furthermore, a variety of more 
specific laws related to infectious disease are used 
for controlling the spread of a wide variety of noti-
fiable diseases including and beyond TB.25 Evidence 
suggests that legislative control of TB transmission 
has recently regained attention due to the threat of 
MDR-TB.26 A recent survey of 14 European coun-
tries identified, mapped, analyzed, and described 
legislative tools used to support tuberculosis con-
trol.27 It found that a wide range of compulsory 
legal measures such as examination, screening, de-
tention, treatment, and vaccination were available 
as ways of protecting public health.28 More specif-
ically, use of compulsory isolation of TB patients 
appears to be commonly provided by the law in 
different countries, with a number of high-burden 
countries having current legislation allowing for 
this practice, including Armenia, Belarus, Georgia, 
the Republic of Moldova, and Ukraine.29 In other 
high-burden countries such as South Africa, pro-
posals for detention have been opposed.30 In most 
countries, literature referred to isolation wards or 
hospitals.31 However, prison-based isolation appears 
to be rare, with cases reported in Israel and Kenya, 
although the facilities in prison differed.32 In Israel, 
patients who are lost to follow-up on treatment 
were either hospitalized under a court order and 
after failing to comply with the order, hospitalized 
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in prison or referred directly to a prison hospital.33 
In Kenya, people lost to follow-up were detained in 
ordinary prisons without health facilities.34
Despite these legal provisions of compulsory 
isolation, human rights literature suggests that 
compulsory treatment infringes on the right to 
health of people lost to follow-up in at least two 
ways. First, this practice generally disregards evi-
dence-based medicine, therefore failing to meet the 
quality requirement of the right to health. Second, 
this practice disregards informed consent, which is 
a critical element of voluntary counseling, testing, 
and treatment.35 However, the right to health of oth-
er members of society cannot be ignored and the 
state has a responsibility to protect the public from 
unnecessary risks of contracting airborne diseases 
and thus must balance involuntary confinement of 
people lost to follow-up with public health protec-
tion of the wider population.36 
The Siracusa Principles, which were adopted 
by the UN Economic and Social Council, allow 
for the limitation of individual rights as a means 
to deal with “a serious threat to the health of the 
population or individual members of the popula-
tions.”37 The Siracusa Principles specify that the 
limitations of individual rights may only occur 
when such limitations are: (1) provided for and 
carried out in accordance with the law; (2) directed 
towards a legitimate objective of general interest; 
(3) strictly necessary in a democratic society; (4) 
the least intrusive and restrictive in severity and 
duration to achieve the objective; and (5) based on 
scientific evidence and neither drafted nor imposed 
arbitrarily nor in a discriminatory manner.38 In 
this context, WHO suggests that interfering with 
freedom of movement when instituting quaran-
tine or isolation for a communicable disease such 
as drug-resistant TB could be legitimate under 
international human rights law. However, WHO 
stresses that “this must be viewed as a last resort, 
and justified only after all voluntary measures to 
isolate such a patient have failed.”39 Most recently, 
for example, individual rights and freedoms were 
curtailed for a limited time within these provisions 
during the Ebola outbreak.40 
Current application of the Public Health Act 
as an instrument for enforcing treatment 
adherence in Kenya
The Public Health Act constitutes Chapter 242 of 
the Laws of Kenya. It has existed since September 
6, 1921, and has been applied as a tool for TB con-
tainment.41 Specifically, Section 27 of the Act makes 
provisions for the mandatory isolation of a person 
with an infectious disease. It states that: 
Where, in the opinion of the medical officer of 
health, any person has recently been exposed to 
the infection, and may be in the incubation stage 
of, or is infectious with any notifiable infectious 
disease and is not accommodated in such manner 
as adequately to guard against the spread of the 
disease, such person may, on a certificate signed by 
the medical officer of health, be removed, by order 
of a magistrate at the cost of the local authority of 
the district where such person is found, to a place 
of isolation and there detained until, in the opinion 
of the medical officer of health, he/she is free from 
infection or able to be discharged without danger 
to the public health, or until the magistrate cancels 
the order.42
In relation to TB, this includes people lost to fol-
low-up on treatment. Because the health system is 
relatively under-resourced, proper isolation facil-
ities in hospitals hardly exist at the district level, 
and people lost to follow-up are instead frequently 
detained in prison where they are compelled to 
take treatment until they complete the full course.43 
Literature suggests that detention in prison is often 
implemented in Kenya, with documented cases in 
2010, 2011, and 2015.44
Impact and appropriateness of prison-based 
mandatory custodial isolation in Kenya
The legal soundness of the compulsory measures 
described in the previous section can be assessed 
against the conditions provided in the Siracusa 
Principles, as well as guidance provided by WHO 
and other key actors of the global health governance 
involved in the response to TB.45 As described 
earlier, the Siracusa Principles only allow for the 
limitation of individual rights as a last resort when 
voluntary measures, on which public health should 
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be based, may be ineffective.46 These limitations 
must be substantiated by scientific evidence.47
The present application of incarceration in 
Kenya raises concerns both in terms of human 
rights law and scientific evidence, thus question-
ing whether application of the Siracusa Principles 
is appropriate and calling for the consideration of 
human rights-based alternatives, which may also 
be effective from a public health point of view. 
 Firstly, in relation to international human rights 
law, compulsory isolation in prison curtails human 
rights as it infringes the right to voluntary informed 
consent, an integral part of the enjoyment of the right 
to health as enshrined in numerous international and 
national human rights instruments and legislation.48 
Article 12 of the International Covenant on Economic, 
Social, and Cultural Rights (ICESCR) addresses the 
right to the highest attainable standard of physical and 
mental health, which includes the right to be free from 
non-consensual medical treatment.49 Incarceration 
also contravenes the freedom of movement of people 
lost to follow-up and could also breach their rights to 
privacy.50 Such detention may cause further spread or 
reinfection with TB when people lost to follow-up are 
held in prisons, which are typically overcrowded and 
poorly ventilated, denying the right to health of fellow 
prisoners, and those lost to follow-up.51 This situation 
also denies access to health facilities and access to 
goods and services that are scientifically appropriate 
and of good quality.52 In this context, the limitations 
of the right to freedom of movement of people lost to 
follow-up are not justified under the Siracusa Princi-
ples, since they fail to contribute to effective TB control 
and sound public health response. This is particularly 
relevant given that a study among prisoners in Kenya 
showed that most prisoners were exposed to, and 
subsequently acquired TB in prison, not outside of it.53 
 Key actors in global health governance, such as 
the Global Fund, encourage human rights responses 
to TB and explicitly acknowledge that “mandatory 
treatment or confinement” could be contributing to 
a rise rather than a reduction of drug-resistant TB, 
therefore undermining the right to health of both 
fellow prisoners without TB and the larger popu-
lation.54 Indeed, WHO asserts that in most cases 
detention approaches are not justified, because 
other less intrusive and less restrictive measures are 
often not exhausted beforehand, as recommended 
by Siracusa Principles.55 This is particularly rele-
vant considering that the application of detention 
measures is rarely proportionate to the risk of 
transmission posed by those who are lost to follow 
up. WHO states that by the time a diagnosis is made, 
household contacts are already exposed to TB and 
the probability of airborne transmission goes down 
markedly after treatment is started.56 Most of the peo-
ple who are incarcerated will have started treatment 
but failed to adhere to it.57 Taken together, these con-
cerns indicate that incarceration is a disproportionate 
response to the failure to adhere to TB treatment. 
 Secondly, global public health is progres-
sively moving away from authoritarian control 
paradigms toward empowering individuals to take 
greater control of their health, as emphasized in the 
1979 Alma-Ata Declaration.58 Fidler et al. argue that 
quarantine and isolation are society’s self-preserva-
tive responses to the threat of contagious diseases.59 
However, as Zachariah et al. contest, an authoritar-
ian paradigm is particularly strong in TB programs 
as exemplified by the popular use of terms such 
as ‘TB control,’ ‘TB suspect,’ and ‘defaulter.’ They 
argue that this is linked to a “paternalistic public 
health approach that makes the public health offi-
cial the decision-maker on behalf of the patient.”60 
In summary, the current approach of mandatory 
custodial isolation disempowers communities and 
is contrary to patient-centered care. Akugizibwe 
and Ramakant further assert that subjecting pa-
tients to punitive public health interventions, which 
they argue is anchored on the historically coercive 
model of TB treatment, could lead to violation of 
patients’ rights and reinforce TB stigma.61 These ob-
servations have partly led the Stop TB Partnership 
to issue global guidance calling for a shift towards 
patient-centered language in TB communication.62 
 Thirdly, mandatory custodial isolation does 
not account for the wider epidemiological and 
health systems context in Kenya, especially the abil-
ity of the health system to support its application as 
intended. This consideration is important because 
in many countries, control of TB is hampered by 
“restricted capacity within overburdened health 
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systems.”63 We contend that in the Kenyan context, 
where 6-7% of an estimated 110,000 people with TB 
are lost each year to follow-up, this policy may not be 
effectively operationalized, because health systems 
are insufficiently resourced in terms of proper isola-
tion wards and human resource capacity.64 Based on 
our findings, the impact of health systems’ capacity 
on the decentralized implementation of mandato-
ry isolation appears not to have been evaluated to 
date. Literature clearly suggests that although some 
countries have legislation permitting involuntary 
isolation of TB patients, some of these countries are 
not applying the legislation as they consider that they 
lack the necessary resources to provide adequate iso-
lation health facilities. Such is the case with Armenia 
and parts of Ukraine.65 Arguably, people lost to fol-
low-up on TB treatment in Kenya are, at least in part, 
punished due to the failings of the health systems. 
 Fourthly, mandatory custodial isolation could 
reinforce existing inequalities through the socio-
economic deprivation of people with TB, thereby 
increasing their vulnerability on the grounds of their 
social and economic status instead of protecting 
them as required by international law.66 Isolation 
for prolonged periods can lead to loss of livelihoods 
for imprisoned people and their families.67 Lack of 
employment itself has been independently associated 
with TB among prisoners in Kenya.68 Loss of income 
for incarcerated patients could drive their depen-
dent families to cheaper, smaller, and potentially 
overcrowded or poorly ventilated housing, further 
increasing their vulnerability to TB. A recent study 
among a general cohort of TB patients from a Ken-
yan slum found that low income was a predictor of 
defaulting treatment.69 
Given that TB occurs mostly among poor 
populations, this can create the potential for a vi-
cious cycle and social patterning of TB that result 
in isolation, loss of livelihoods and employment, re-
location to cheaper housing, recurrence of TB, and 
further loss to follow-up and subsequent incarcera-
tion. Owing to the underlying population clustering 
of economically disadvantaged social groups in 
deprived slums, this has led to what Kawachi et al. 
refer to as ‘spatial disease patterns’—where slums 
have differentially high rates of TB in Kenya, in-
cluding MDR-TB.70 It is not surprising that among 
urban poor in Kenya, previous loss to follow-up 
is a strong predictor of future loss to follow-up.71 
 Finally, mandatory isolation of people lost to 
follow-up could adversely affect their psychological 
well-being, thus undermining their right to achieve 
their highest attainable standard of mental health.72 
As Zachariah et al. and Akugizibwe and Ramakant 
argue, punitive measures could inadvertently 
result in people lost to follow-up being treated 
like criminals.73 Considering that in Kenya, man-
datory isolation takes place in prisons, and thus 
people lost to follow up are imprisoned like other 
inmates, this approach equates to criminalization 
of poor compliance with treatment.74 This dispro-
portionately punishes people lost to follow-up, 
and their families and dependents, fueling the 
perception that they are criminals requiring disci-
plinary treatment approaches, and may undermine 
health-promotion initiatives, perpetuate stigma, 
and increase health risks of the wider populations.75 
 The resulting stress and social exclusion asso-
ciated with criminalization could lead to substance 
abuse, poor health outcomes, and an exacerbation 
of health inequalities through psychosocial path-
ways.76 A study conducted in Kenya in 2011 showed 
that the odds of a person lost to follow-up on TB 
treatment being an alcohol abuser were up to five 
times that of someone adhering to treatment.77 In 
addition, coercive measures can reinforce stigma, 
which is an important determinant of treatment 
completion in Kenya.78 In summary, incarceration 
and detention approaches are likely to exacerbate 
pre-existing social inequities. 
Human rights-based alternatives
The suitability of detention to the Kenyan con-
text remains contentious and there are numerous 
concerns regarding its impact on both individual 
human rights and collective public health interests. 
We suggest that potential alternative solutions fall 
into three broad categories: preventing primary loss 
to follow-up, improving premises and conditions 
of isolation, and amending public health laws to 
exclude prison as a setting for mandatory isolation. 
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The combination of these measures aims to offer 
alternatives to current detention approaches that 
infringe on the rights of people lost to follow-up 
without compromising public health TB control.
Primary prevention of loss to follow-up
Understanding why people get lost to follow-up is 
central to our proposed potential solutions. The 
reasons people stop TB treatment, and how they 
can be best supported to adhere and complete full 
course of treatment, need to be understood from 
an individual, household, and community per-
spective.79 Studies suggest that common reasons 
people on treatment for TB are lost to follow-up 
include lack of adequate knowledge about TB, lack 
of adequate family support, cultural beliefs which 
curtail health seeking, and living a long distance 
from health facilities (Table 1).80 WHO asserts 
that non-adherence is often a direct consequence 
of failure to educate and engage people with TB 
in the treatment process, which is common in the 
TB sector.81 Hence, counseling people with TB, 
strengthening treatment literacy, and respectful 
engagement of TB patients to enable them to 
make informed decisions regarding treatment 
could potentially reduce rates of loss to follow-up. 
In addition, such patient-centered strategies are 
consistent with a human rights approach as they 
promote access to essential physical, informational, 
and economic elements of the right to health.82
Although it is not the intention of this paper 
to comprehensively review all causal reasons, our 
view is that socioeconomic factors, such as poverty, 
lack of employment, lack of transport, and poor 
housing, are central to both the acquisition of TB 
and loss to follow-up, and that these factors are not 
easily amenable to vertical interventions such as 
incarceration. A systematic review conducted by 
Munro et al. identified similar social and structural 
factors as key drivers of poor adherence globally.83 
In Kenya, there is a significant policy focus on 
health promotion and education, tracing persons 
lost to follow-up, and enforcing treatment comple-
tion.84 However, there is little focus on countering 
some of the social-structural reasons for stopping 
TB treatment, such as long distances to health fa-
cilities, poverty, gender, and alcohol abuse, as part 
of TB interventions.85 A fundamental argument 
against focusing on medical, educational, or legal 
interventions such as incarceration is that doing 
so does not address important structural drivers 
of stopping TB treatment.86 Therefore, to prevent 
primary loss to follow-up, structural interventions 
are also required, and implementing these may re-
quire multi-sectoral partnerships beyond the remit 
of a typical national TB program.87 In addition, 
addressing the social determinants of adhering to 
TB treatment could potentially reduce both the 
incidence of TB and loss to follow-up.
Alternatives to detention-based approaches
The second solution is focused on finding alter-
natives to the ongoing use of prisons as spaces for 
isolation. This could be achieved by strengthening 
health systems to increase the capacity of hospitals, 
decentralizing provision of TB medications deep 
into communities, and providing functional iso-
lation wards and hospitals. Hence, isolation could 
be conducted within isolation health facilities ap-
propriate for that purpose. In addition, evidence 
suggests that community-based adherence support 
can be a viable alternative; WHO supports a com-
munity-based treatment approach.88 The primary 
aim of alternatives to incarceration is to achieve 
infection control to prevent spread of TB, and at the 
same time respect the dignity and human rights of 
those lost to follow-up, ensuring that they are free 
from stigma and dehumanizing treatment and, 
where possible, enjoy freedom of movement.89 
Revision of the Public Health Act and 
formulation of new isolation policy
The third human rights-based solution we propose 
is to amend the Public Health Act to clearly indi-
cate that prisons should not be used for enforcing 
treatment. The ground for this has recently been 
laid. Pursuant to petition 329 of 2014 in the High 
Court of Kenya at Nairobi, a determination was 
made—while our research was in progress—making 
it unconstitutional to confine persons with TB in pris-
on for the purpose of treatment enforcement on the 
basis of the Public Health Act.90 In addition, the court 
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Table 1. Factors associated with loss to follow-up in Kenya and possible public health interventions to address them.
Study (source)
Primary reasons 
contributing to loss to 
follow up
Underlying causal 
factors
Potential intervention 
levels
Suggested interventions and 
multidisciplinary approaches
Muture et al., 2011 
Owiti, 2008
Inadequate knowledge 
of TB and its treatment
Health literacy Individual Educate patients at TB clinics and their 
communities at schools, churches, youth 
groups, and community centers. There is 
a role for teachers, nurses, counselors, and 
community leaders.
Muture et al., 2011 
Owiti, 2008
Feeling better, 
ignorance, cultural 
beliefs 
Health-seeking 
behaviors 
Individual and 
community
Muture et al., 2011 Use of herbal 
medication
Cultural traditions, 
health seeking 
behavior
Individual and 
community
Work with local herbalists so that they 
do not prescribe herbal drugs but instead 
refer patients back to health and DOT 
centers.
Muture et al, 2011 
Kizito et al., 2011
Lack of salaried 
employment, low 
income 
Economic factors Structural Work with social services to improve 
employability of people with TB disease, 
and non-governmental sector for 
livelihoods, conditional cash transfers, or 
microfinance.
Muture et al., 2011 Alcohol abuse Economic, 
psychological factors
Social structural Work with national alcohol abuse agency 
and alcoholic anonymous and counselors 
to mitigate alcohol abuse among people 
lost to follow-up.
Muture et al., 2011 
Kizito et al., 2011
Male gender (poor 
health-seeking among 
men) 
Gender, economic 
factors
Social structural Gender transformative interventions to 
improve health-seeking behavior among 
men, and improve their livelihood 
opportunities. Role for counselors and 
peer educators.
Muture et al., 2011 Previous loss to 
follow-up
Social economic Social structural Ensure surveillance of people lost to 
follow-up by working with family 
members and community health workers.
Kizito et al., 2011 Lack of family support Social economic Individual, 
community, and social 
structural
Ensure that communities are engaged in 
the delivery of care at home, that they 
know how to prevent getting infected 
from an index case. Role for health care 
providers, community health workers, and 
others.
Wasonga et al., 2006 Poor housing Social economic Structural Upgrade slums and improve housing for 
the poor. Potential role for ministry of 
housing, social workers, private sector, 
non-governmental organizations, and the 
national TB control program.
Muture et al, 2011 
Wasonga et al., 2006
Side effects, drugs too 
strong 
Drug safety and 
tolerability
Structural Improve the quality of drugs. Provide 
treatment education to enable patients 
understand, report or cope with side 
effects. Role for private pharmaceutical 
organizations and health workers.
Muture et al., 2011 Long distances to 
treatment sites
Health system 
availability 
Structural Decentralize services, engage mobile 
services to reach marginalized 
populations, engage community health 
workers. Needs multidisciplinary teams 
composed of clinicians, medical officers of 
health, non-governmental organizations, 
and community health workers.
G. Mburu, E. Restoy, E. Kibuchi, P. Holland, and A. D. Harries  / TB and the Right to Health, 43-54
   J U N E  2 0 1 6    V O L U M E  1 8    N U M B E R  1   Health and Human Rights Journal 51
ordered appropriate policies for the confinement of 
persons with TB and other infectious diseases to be 
formulated by the Ministry of Public Health. The text 
of the Public Health Act therefore needs to be amend-
ed to be consistent with the above judgment, given the 
reliance on the Act for public health protection.
Consequently, development of progressive 
policies is now required. The Ministry of Public 
Health should strengthen community-based sup-
port. The new policy could require health care 
workers to provide adherence support to lost to 
follow up TB patients in their homes, for exam-
ple through periodic home visits, as is the case in 
other countries that have shifted from detention 
approaches.91 Community health workers, who 
have effectively supported adherence to HIV treat-
ment, could be a suitable alternative for performing 
this role, given existing human resource capacity 
constraints.92 In addition, new policies should em-
phasise the importance of patient engagement in 
treatment decisions and the rights of TB patients.93 
 Given this paradigm shift, it is critical that 
the Ministry of Public Health provides training 
and resources to respect and protect these rights 
within health care facilities in the context of 
patient-centered care and infection control. Fur-
ther, new policies should emphasize that even for 
non-adherent persons, isolation in proper health 
facilities should only be the last resort and even 
then, such patients could still choose not to take 
medications. In such a scenario, isolation could 
only be useful for public health protection for the 
limited duration of infectiousness, as emphasized by 
WHO.94 To be effective, a range of socio-economic 
and structural interventions highlighted in Table 1 
should form a central part of new policies anchored 
on social support, as recommended by WHO.95 
Conclusions
We have presented a range of less restrictive and 
human rights-based alternatives to incarceration 
and detention-based approaches as a means of en-
forcing treatment of TB. We have illustrated ways 
in which such incarceration and detention-based 
approaches are contrary to international human 
rights provisions, and indeed, how they could 
worsen social inequalities and lead to paradoxical 
outcomes in regard to TB. In light of the recent case 
in the High Court of Kenya at Nairobi forbidding 
use of prisons as a place of mandatory isolation for 
people who have stopped their TB treatment, we 
suggest that there is a need to strengthen the health 
systems to reduce dependency on prisons as isola-
tion spaces by creating proper isolation facilities, 
wards, and hospitals, further decentralize services 
to communities, and revise the Public Health Act 
and formulate a new isolation policy. In addition, 
collaboration with other sectors to address so-
cio-economic and structural determinants of TB 
infection and loss to follow-up is required. 
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